Skip to content

Prospective evaluation of Quality of Life in head and neck cancer patients treated with palliative radiotherapy

Prospective evaluation of Quality of Life in head and neck cancer patients treated with palliative radiotherapy - PallRad-KHT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021197
Enrollment
70
Registered
2020-03-30
Start date
2020-06-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00 C01 C02 C03 C04 C04 C05 C06 C09 C10 C11 C12 C13 C14 C30 C31 C32 C33

Interventions

Group 1: palliative radiotherapy

Sponsors

Universitätsklinikum Schleswig-Holstein Campus Kiel
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: squamous cell head and neck cancer; indication for palliative radiotherapy; ability to fill out questionnaires; age at least 18yrs; informed consent

Exclusion criteria

Exclusion criteria: radiotherapy with curative intend (EQD2 = 60 Gy); cutaneous primary; legal incapacity or missing informed consent

Design outcomes

Primary

MeasureTime frame
Quality of life as measured by the questionnaires EORTC QLQ C-30+H&N43 before and after radiotherapy (descriptive statistics, but mandatory reporting of QoL domains "global QoL", "Pain - mouth", "swallowing", "Fatigue", and "physical funtioning" at 2 months after radiotherapy; the observation period will be from before the onset of radiotherapy to 12 months after radiotherapy in intervals)

Secondary

MeasureTime frame
toxicity (CTCAE), frequency of unplanned hospital admissions, evolution of performance status and intake of analgesics, satisfaction with therapy, overall survival (the observation period will be from before the onset of radiotherapy to 18 months after radiotherapy in intervals)

Countries

Germany

Contacts

Public ContactAlexander Fabian

Klinik für Strahlentherapie, UKSH , Kiel

alexander.fabian@uksh.de043150026557

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026